Limei Wang
Impact in
- Pollution top 2%
- Pharmaceutical and Antibiotic Environmental Impacts
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
Papers in ⓘ
-
- Advanced biosensing and bioanalysis techniques 11
- RNA Interference and Gene Delivery 9
- Gene expression and cancer classification 8
- Bioinformatics and Genomic Networks 8
- Immunology 35
- Immune Response and Inflammation 7
- Co-authors
- Bingjie Xu (1 shared paper)Yi Luo (1 shared paper)Lin Xu (1 shared paper)Daqing Mao (1 shared paper)Yong Cheng (5 shared papers)Bin Qi (7 shared papers)Xiuliang Zhao (5 shared papers)Toshiyuki Mera (1 shared paper)
- Journals
- Molecules (7 papers)Scientific Reports (5 papers)Ceramics International (4 papers)International Immunopharmacology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Limei Wang
214 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 165
- Pollution 552
- Molecular Medicine 228
- Immunology 720
- Molecular Biology 1.9k
- Cancer Research 319
Countries citing papers authored by Limei Wang
This map shows the geographic impact of Limei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Limei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Limei Wang more than expected).
Fields of papers citing papers by Limei Wang
This network shows the impact of papers produced by Limei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Limei Wang. The network helps show where Limei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Limei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 230 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Occurrence of sulfonamide and tetracycline-resistant bacteria and resistance genes in aquaculture environment Hit paper breakdown → | 2012 | 574 |
| 2 | 2015 | 145 | |
| 3 | 2013 | 138 | |
| 4 | 2007 | 135 | |
| 5 | Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. | 2004 | 120 |
| 6 | 2021 | 113 | |
| 7 | 2017 | 96 | |
| 8 | 2008 | 89 | |
| 9 | 2020 | 84 | |
| 10 | 2023 | 78 | |
| 11 | 2020 | 76 | |
| 12 | 2022 | 72 | |
| 13 | 2022 | 70 | |
| 14 | 2015 | 65 | |
| 15 | 2015 | 57 | |
| 16 | 2008 | 55 | |
| 17 | 2015 | 55 | |
| 18 | 2019 | 53 | |
| 19 | 2015 | 53 | |
| 20 | 2021 | 51 |
About Limei Wang
Limei Wang is a scholar working on Molecular Biology, Immunology, Oncology, Cancer Research and Surgery, having authored 230 papers that have together received 4.7k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (11 papers), RNA Interference and Gene Delivery (9 papers), Gene expression and cancer classification (8 papers), Advanced materials and composites (8 papers), Bioinformatics and Genomic Networks (8 papers), Tuberculosis Research and Epidemiology (7 papers), Immune Response and Inflammation (7 papers) and Cancer-related molecular mechanisms research (7 papers). The work is most often cited by research in Pollution (552 citations), Molecular Medicine (228 citations), Immunology (720 citations), Molecular Biology (1.9k citations) and Cancer Research (319 citations). Limei Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Bingjie Xu, Yi Luo, Lin Xu, Daqing Mao, Yong Cheng, Bin Qi, Xiuliang Zhao, Toshiyuki Mera, Denise L. Faustman and Yoshiaki Okubo. Their work appears in journals such as Molecules, Scientific Reports, Ceramics International, International Immunopharmacology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.